WM Technology MAPS 深 沪
等待开盘 05-11 09:30:00 美东时间
0.4379
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.4379
- 总市值 3.77万
- 52周最高 1.359
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.32
- 委 比 0.00%
- 总股本 8.61万
- 历史最高 29.50
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.32
- 每 手 1
- 风险率 0.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cleveland-Cliffs, Steel Dynamics And 3 Stocks To Watch Heading Into Monday
US stock futures lower, with investors eyeing companies such as Cleveland-Cliffs, Steel Dynamics, WM Technology, Zions Bancorporation, and Alaska Air.
04-20 17:50
WM Technology To Voluntary Delist From Nasdaq
WM Technology, Inc. ("WM Technology" or the "Company") (NASDAQ:MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced its decision to voluntarily delist its Class A
04-08 05:01
'Medicare CBD Pilot Will Allow Some THC in Products'- Cannabis Wire
https://cannabiswire.com/newsletters/scoop-medicare-cbd-pilot-will-allow-some-thc-in-products/?free_read=1773920530418
03-19 22:30
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
https://abcnews.go.com/Politics/trump-sign-executive-order-reclassifying-marijuana-officials/story?id=128472615
2025-12-17 21:38
President Trump Says Considering Executive Oder To Reclassify Marijuana
https://www.youtube.com/watch?v=hWb2pJuZyrQ
2025-12-16 04:45
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
WestPark Capital Reiterates Buy on WM Tech, Maintains $2.61 Price Target
WestPark Capital analyst Casey Ryan reiterates WM Tech (NASDAQ:MAPS) with a Buy and maintains $2.61 price target.
2025-03-11 20:13
NASDAQ-Listed Cannabis Giant Misses Tech Rally: What Investors Need To Know About MAPS' Stock
MAPS has been reinvesting cost savings into advertising, product development, and emerging markets according to a Monday night analyst report
2024-09-17 21:38
Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
Lykos Therapeutics CEO Amy Emerson steps down following the FDA's rejection of the company's MDMA-based PTSD therapy.
2024-09-06 05:31
